Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Upstream Bio, Inc. shareholders approved Election of Class II Directors at the 2026-06-09 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
The Company’s stockholders approved the Class II director nominees recommended for election in Proposal 1 at the Annual Meeting. The results of Proposal 1 were as follows: Class II Director Nominee For Withheld Broker Non-Votes H. Edward Fleming, Jr., M.D. 40,715,035 3,367,258 4,018,474 Liam Ratcliffe, M.B.Ch.B., Ph.D., M.B.A. 43,812,021 270,272 4,018,474
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Upstream Bio, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
Proposal 2 - Ratification of Appointment of the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of PwC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of Proposal 2 were as follows: For Against Abstain 47,951,313 143,251 6,203
View on SEC.gov